Results for “ ”

Entry Author Date Location
QurAlis Hauls In $42M to Move New ALS Therapies Into Human Testing 05/13/20 Boston
Dyno Debuts With Plan, Partnerships for Better Gene Therapy Vectors 05/11/20 Boston
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs 05/04/20 Boston
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses 05/01/20 Boston
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle 04/23/20 National
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
War Paint to Bone Paint: MIT Spinout Aims to Transform Regenerative Meds 04/21/20 Boston
Unlearn Adds $12M for “Digital Twins” That Accelerate Clinical Trials 04/20/20 San Francisco
RDMD Lands $14M to Expand Reach of Rare Disease Research Platform 04/16/20 San Francisco
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer 04/15/20 Boston
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs 04/03/20 Boston
Flagship Adds $1.1B for New Meds, More AI, & “Health Security” 04/02/20 National
Pandion Pulls In $80M as Ulcerative Colitis Drug Advances in Clinic 04/01/20 Boston
Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus 03/31/20 Europe
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
How San Diego Biotech Leaders Are Adapting to Coronavirus Concerns 03/19/20 San Diego
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic 03/12/20 Boston
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund 03/11/20 Europe
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers 03/02/20 San Francisco
Invetx Fetches $15M to Develop Biologic Drugs for Man’s Best Friend 02/24/20 Boston
Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More 02/21/20 National
Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug 02/20/20 San Francisco
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device 02/19/20 Boston
Page 2 of 502 « previous page · next page »